mr. jankowski: trying to think of the right answer to your question. your question was, -- >> how do we deal with the unknown unknowns of synthetic biology? maybe it's genome editing or something much more general. mr. jankowski: i can tell you how we do it at biocurious, how i think personally about it. we have a safety board that reviews each project that comes in. we're a b.s.l. 1 lab, biosafety level one, which is simple requirements. there's nothing pathogenic new -- pathogenic, no human cells, nothing that can be harm to feel humans. we look at the projects that come in. look in a different direction, to me, safety is around bring manager people into the work and into the conversation. i think that the brca-1 experiment i talked about was one thing. it's not about bringing people to be pro science. it's an opportunity for science outreach they feel word "outreach," you're kind of like grabbing for people, to grab them or something. i think the opportunity is really to go to where people are, talk about topics that they're interested. in brca-1 is